The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 246.50
Bid: 247.00
Ask: 248.00
Change: -0.50 (-0.20%)
Spread: 1.00 (0.405%)
Open: 245.50
High: 248.50
Low: 245.50
Prev. Close: 247.00
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - SPIRE HEALTHCARE GROUP PLC

16 Nov 2017 11:54

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose SPIRE HEALTHCARE GROUP PLC
relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 15 November 2017
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? MEDICLINIC INTERNATIONAL PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 1p ordinary
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 2,416,593 0.60% 1,601,953 0.40%
(2) Cash-settled derivatives:
931,840 0.23% 890,257 0.22%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 0 0.00% 0 0.00%
(4)
TOTAL: 3,348,433 0.83% 2,492,210 0.62%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
1p ordinary Purchase 158 2.9940 GBP
1p ordinary Purchase 284 2.9860 GBP
1p ordinary Purchase 284 2.9856 GBP
1p ordinary Purchase 372 2.9610 GBP
1p ordinary Purchase 609 2.9680 GBP
1p ordinary Purchase 3,922 2.9626 GBP
1p ordinary Purchase 4,271 2.9658 GBP
1p ordinary Purchase 5,311 2.9603 GBP
1p ordinary Purchase 5,409 2.9714 GBP
1p ordinary Purchase 34,596 2.9685 GBP
1p ordinary Sale 284 2.9860 GBP
1p ordinary Sale 363 2.9680 GBP
1p ordinary Sale 1,192 2.9600 GBP
1p ordinary Sale 3,734 2.9658 GBP
1p ordinary Sale 5,561 2.9660 GBP
1p ordinary Sale 14,425 2.9606 GBP

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
1p ordinary CFD Long 363 2.9679 GBP
1p ordinary CFD Long 1,192 2.9600 GBP
1p ordinary SWAP Long 1,690 2.9634 GBP
1p ordinary CFD Long 2,691 2.9386 GBP
1p ordinary CFD Long 3,734 2.9658 GBP
1p ordinary CFD Long 11,038 2.9689 GBP
1p ordinary SWAP Long 11,334 2.9660 GBP
1p ordinary CFD Short 246 2.9680 GBP
1p ordinary CFD Short 372 2.9610 GBP
1p ordinary SWAP Short 1,200 2.9715 GBP
1p ordinary SWAP Short 1,417 2.9718 GBP
1p ordinary CFD Short 1,444 2.9452 GBP
1p ordinary SWAP Short 3,516 2.9591 GBP
1p ordinary SWAP Short 4,773 2.9740 GBP
1p ordinary SWAP Short 34,596 2.9685 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 16 Nov 2017
Contact name: Jay Supaya
Telephone number: 020 7773 0635

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171116005720/en/

Copyright Business Wire 2017

Date   Source Headline
14th Oct 202210:00 amRNSChanges to Board of Directors and committees
3rd Oct 20224:04 pmRNSTotal Voting Rights
30th Sep 20227:00 amRNSBlock Listing Six Monthly Return
8th Sep 20227:00 amRNSInterim Results
1st Sep 20229:51 amRNSTotal Voting Rights
23rd Aug 20222:55 pmRNSHolding(s) in Company
15th Aug 20227:00 amRNSNotice of Interim Results
4th Aug 20222:11 pmRNSHolding(s) in Company
1st Aug 20222:43 pmRNSTotal Voting Rights
19th Jul 20229:07 amRNSBlock listing Interim Review
14th Jul 20223:48 pmRNSHolding(s) in Company
13th Jul 20224:43 pmRNSHolding(s) in Company
6th Jul 20224:00 pmRNSDirector/PDMR Shareholding
1st Jul 202210:28 amRNSTotal Voting Rights
29th Jun 20223:56 pmRNSHolding(s) in Company
29th Jun 20227:00 amRNSCapital Markets Event and new agreement with BUPA
1st Jun 20227:54 amRNSTotal Voting Rights
19th May 20227:44 amRNSHolding(s) in Company
18th May 20223:15 pmRNSHolding(s) in Company
13th May 202210:43 amRNSDirector/PDMR Shareholding
11th May 20224:25 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
6th May 20227:00 amRNSNotice of Capital Markets Day
3rd May 20228:46 amRNSTotal Voting Rights
27th Apr 20223:49 pmRNSDirector/PDMR Shareholding
6th Apr 20229:55 amRNSDirector/PDMR Shareholding
1st Apr 20224:40 pmRNS2021 Annual Report and 2022 Notice of AGM
1st Apr 202212:32 pmRNSHolding(s) in Company
1st Apr 202211:10 amRNSTotal Voting Rights
25th Mar 20222:51 pmRNSBlock listing application
24th Mar 20225:16 pmRNSHolding(s) in Company
16th Mar 20228:07 amRNSDirector/PDMR Shareholding
9th Mar 20227:43 amRNSHolding(s) in Company
4th Mar 20226:12 pmRNSHolding(s) in Company
4th Mar 20223:14 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
1st Mar 20227:23 amRNSTotal Voting Rights
25th Feb 202212:21 pmRNSHolding(s) in Company
25th Feb 20227:00 amRNSRe-financing of funding facilities
22nd Feb 20223:26 pmRNSHolding(s) in Company
22nd Feb 20221:38 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSManagement update
8th Feb 20227:00 amRNSNotice of Preliminary Results
1st Feb 20229:29 amRNSTotal Voting Rights
27th Jan 20222:57 pmRNSTotal Voting Rights
18th Jan 20227:00 amRNSUpdate on shareholder views
13th Jan 20224:52 pmRNSHolding(s) in Company
12th Jan 20222:40 pmRNSHolding(s) in Company
12th Jan 20222:38 pmRNSHolding(s) in Company
11th Jan 202210:14 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.